Skip to main content
. Author manuscript; available in PMC: 2018 Jul 6.
Published in final edited form as: ChemMedChem. 2017 Jun 12;12(13):1033–1044. doi: 10.1002/cmdc.201700196

Figure 4.

Figure 4

Complex II inhibitors with greater potency convey greater cytotoxicity. A) Dose-response curve of the effect of complex II inhibitor 16k on percentage cell viability of 22Rv1 prostate cancer cells. B) Dose-response curve of effect of complex II inhibitor 16k on the percentage cell viability of low tumorigenic HEK293 cells. Cell viability measured after 48-hour incubation of compound. Values are the mean ± S.D. of triplicate experiments.